Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| WES-20 | HIV20BL | U.S. | 1991 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | NA |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| M41L, D67N, T215Y | V75I | V35I, K166R, T200A, R211K |
| >HIV20BL| codons 16-227 MDGPKVKQWPLTEEKIKALIEICTELEKEGKISKIGPENPYNTPVFAIKKKNSTKWRKLI DFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSI NNETPGIRYQYNVLPQGWKGSPAIFQSSMTRILEPFRKQNPDIVIYQYMDDLYVGSDLEI GQHRAKIEELRQHLLKWGFYTPDKKHQKEPPF |
References
| Author | Title | Citation |
| Naugler, WE | T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. | J Infect Dis, 2002 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |